ZRANB1 can decelerate the ubiquitination of Sox9 to stabilize it in CRC cells, which enhances activation of the downstream USP22/Wnt/β-catenin pathway to increase stem-cell-like properties and promote tumor progression [86]. Here, USP22 is linked to colorectal carcinoma.